Cited by 141Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac pacing and defibrillation studies

The DOI matches its Crossref record; 227 of the 227 references it cites were found in a registry or an index.

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

Open access

Kirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., Bailleul, C., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., Boersma, L., Boriani, G., Brandes, A., Brown, H., Brueckmann, M., Calkins, H., Casadei, B., Clemens, A., Crijns, H., Derwand, R., Dobrev, D., Ezekowitz, M., Fetsch, T., Gerth, A., Gillis, A., Gulizia, M., Hack, G., Haegeli, L., Hatem, S., Georg Hausler, K., Heidbuchel, H., Hernandez-Brichis, J., Jais, P., Kappenberger, L., Kautzner, J., Kim, S., Kuck, K.-H., Lane, D., Leute, A., Lewalter, T., Meyer, R., Mont, L., Moses, G., Mueller, M., Munzel, F., Nabauer, M., Nielsen, J. C., Oeff, M., Oto, A., Pieske, B., Pisters, R., Potpara, T., Rasmussen, L., Ravens, U., Reiffel, J., Richard-Lordereau, I., Schafer, H., Schotten, U., Stegink, W., Stein, K., Steinbeck, G., Szumowski, L., Tavazzi, L., Themistoclakis, S., Thomitzek, K., Van Gelder, I. C., von Stritzky, B., Vincent, A., Werring, D., Willems, S., Lip, G. Y. H., Camm, A. J.·2013·Europace

DOI 10.1093/europace/eut232

Open this paper in CoChat — free account Open PDF

Abstract

The management of atrial fibrillation (AF) has seen marked changes in past years, with the introduction of new oral anticoagulants, new antiarrhythmic drugs, and the emergence of catheter ablation as a common intervention for rhythm control. Furthermore, new technologies enhance our ability to detect AF. Most clinical management decisions in AF patients can be based on validated parameters that encompass type of presentation, clinical factors, electrocardiogram analysis, and cardiac imaging. Despite these advances, patients with AF are still at increased risk for death, stroke, heart failure, and hospitalizations. During the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association (AFNET/EHRA) consensus conference, we identified the following opportunities to personalize management of AF in a better manner with a view to improve outcomes by integrating atrial morphology and damage, brain imaging, information on genetic predisposition, systemic or local inflammation, and markers for cardiac strain. Each of these promising avenues requires validation in the context of existing risk factors in patients. More importantly, a new taxonomy of AF may be needed based on the pathophysiological type of AF to allow personalized management of AF to come to full fruition. Continued translational research efforts are needed to personalize management of this prevalent disease in a better manner. All the efforts are expected to improve the management of patients with AF based on personalized therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/europace/eut232

Cites

227 of 227 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Preoperative statin therapy for patients undergoing cardiac surgery
Liakopoulos, O. J., Kuhn, E. W., Slottosch, I., Wassmer, G., & Wahlers, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008493.pub2 · Cited by 145
Retracted
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Self-citation
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,924
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · CHEST Journal · doi:10.1378/chest.10-0134 · Cited by 4,517
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,823
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S.-A., Crijns, H. J. G., Damiano, R. J., Davies, D. W., DiMarco, J., et al. (2012) · Europace · doi:10.1093/europace/eus027 · Cited by 2,722
American Journal of Neuroradiology
(2020) · American Journal of Neuroradiology · doi:10.3174/ajnr · Cited by 2,468
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis
Debette, S., & Markus, H. S. (2010) · BMJ · doi:10.1136/bmj.c3666 · Cited by 2,328
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
Holmes, D. R., Reddy, V. Y., Turi, Z. G., Doshi, S. K., Sievert, H., Buchbinder, M., Mullin, C. M., & Sick, P. B. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61343-x · Cited by 2,242
Subclinical atrial fibrillation and the risk of stroke
Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., Van Gelder, I. C., Capucci, A., Lau, C. P., Fain, E., Yang, S., Bailleul, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105575 · Cited by 2,100
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
The International Consortium for Blood Pressure Genome-Wide Association Studies (2011) · Nature · doi:10.1038/nature10405 · Cited by 2,033
Cerebral microbleeds: a guide to detection and interpretation
Greenberg, S. M., Vernooij, M. W., Cordonnier, C., Viswanathan, A., Al-Shahi Salman, R., Warach, S., Launer, L. J., Van Buchem, M. A., & Breteler, M. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70013-4 · Cited by 1,798
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · EP Europace · doi:10.1093/europace/euq350 · Cited by 1,764
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)
Wann, L. S., Curtis, A. B., January, C. T., Ellenbogen, K. A., Lowe, J. E., Estes, N. A. M., Page, R. L., Ezekowitz, M. D., Slotwiner, D. J., Jackman, W. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181fa3cf4 · Cited by 1,338
Pathophysiological mechanisms of atrial fibrillation: a translational appraisal
Schotten, U., Verheule, S., Kirchhof, P., & Goette, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00031.2009 · Cited by 1,273
Silent brain infarcts: a systematic review
Vermeer, S. E., Longstreth, W. T., & Koudstaal, P. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70170-9 · Cited by 1,221
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation: A Randomized Controlled Trial
Wilber, D. J., Pappone, C., Neuzil, P., De Paola, A., Marchlinski, F., Natale, A., Macle, L., Daoud, E. G., Calkins, H., Hall, B., et al. (2010) · JAMA · doi:10.1001/jama.2009.2029 · Cited by 1,170
Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
Hohnloser, S. H., Crijns, H. J. G. M., van Eickels, M., Gaudin, C., Page, R. L., Torp-Pedersen, C. T., & Connolly, S. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803778 · Cited by 1,125
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
Watson, T., Shantsila, E., & Lip, G. Y. H. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60040-4 · Cited by 1,124
Detection and Quantification of Left Atrial Structural Remodeling With Delayed-Enhancement Magnetic Resonance Imaging in Patients With Atrial Fibrillation
Oakes, R. S., Badger, T. J., Kholmovski, E. G., AKOUM, N. W., Burgon, N. S., Fish, E. N., Blauer, J. J. E., Rao, S. N., DiBella, E., Segerson, N. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.811877 · Cited by 1,123
Left Atrial Size and the Risk of Stroke and Death
Benjamin, E. J., D’Agostino, R. B., Belanger, A. J., Wolf, P. A., & Levy, D. A. (1995) · Circulation · doi:10.1161/01.cir.92.4.835 · Cited by 1,058
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study
Schnabel, R. B., SULLIVAN, L. M., Levy, D. A., Pencina, M. J., Massaro, J. M., D’Agostino, R. B., Newton‐Cheh, C., Yamamoto, J. F., Magnani, J. W., Tadros, T. M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60443-8 · Cited by 1,038
Variants conferring risk of atrial fibrillation on chromosome 4q25
Gudbjartsson, D. F., Arnar, D. O., Helgadottir, A., Gretarsdottir, S., Holm, H., Sigurdsson, A., Jonasdottir, A., Baker, A., Thorleifsson, G., Kristjansson, K., et al. (2007) · Nature · doi:10.1038/nature06007 · Cited by 955
Stroke and bleeding in atrial fibrillation with chronic kidney disease
Olesen, J. B., Lip, G. Y. H., Kamper, A.-L., Hommel, K., Køber, L., Lane, D. A., Lindhardsen, J., Gislason, G. H., & Torp-Pedersen, C. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105594 · Cited by 930
Self-citation
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Huezey, J.-Y. L., Lowe, J. E., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.013 · Cited by 928
Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds.
(1999) · PubMed Central · Cited by 924
Does the Left Atrial Appendage Morphology Correlate With the Risk of Stroke in Patients With Atrial Fibrillation?
Biase, L. D., Santangeli, P., Anselmino, M., Mohanty, P. K., Salvetti, I., Gili, S., Horton, R., Sánchez, J., Bai, R., Mohanty, S., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.032 · Cited by 876
Safety of Percutaneous Left Atrial Appendage Closure
Reddy, V. Y., Holmes, D. R., Doshi, S. K., Neužil, P., & Kar, S. (2011) · Circulation · doi:10.1161/circulationaha.110.976449 · Cited by 863
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214876d · Cited by 859
Self-citation
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. (2013) · Europace · doi:10.1093/europace/eut083 · Cited by 792
Prediction of Cardiovascular Outcomes With Left Atrial Size
Tsang, T. S. M., Abhayaratna, W. P., Barnes, M. E., Miyasaka, Y., Gersh, B. J., Bailey, K. R., Cha, S. S., & Seward, J. B. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.077 · Cited by 777
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations
Gouw, A. A., Seewann, A., van der Flier, W. M., Barkhof, F., Rozemuller, A. M., Scheltens, P., & Geurts, J. J. G. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.204685 · Cited by 766
Amiodarone versus sotalol for atrial fibrillation
Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., Fletcher, R. D., Sharma, S. C., Atwood, J. E., Jacobson, A. K., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041705 · Cited by 749
Self-citation
Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy
Olivotto, I., Cecchi, F., Casey, S. A., Dolara, A., Traverse, J. H., & Maron, B. J. (2001) · Circulation · doi:10.1161/hc4601.097997 · Cited by 745
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation
Cosedis Nielsen, J., Johannessen, A., Raatikainen, P., Hindricks, G., Walfridsson, H., Kongstad, O., Pehrson, S., Englund, A., Hartikainen, J., Mortensen, L. S., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113566 · Cited by 720
Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting
Cordonnier, C., Al-Shahi Salman, R., & Wardlaw, J. (2007) · Brain · doi:10.1093/brain/awl387 · Cited by 703
Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia
Ramanathan, C., Ghanem, R. N., Jia, P., Ryu, K., & Rudy, Y. (2004) · Nature Medicine · doi:10.1038/nm1011 · Cited by 646
Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter
Singh, B. N., Connolly, S. J., Crijns, H. J. G. M., Roy, D., Kowey, P. R., Capucci, A., Radzik, D., Aliot, E., & Hohnloser, S. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa054686 · Cited by 638
Dronedarone in High-Risk Permanent Atrial Fibrillation
Connolly, S. J., Camm, A. J., Halperin, J. L., Joyner, C., Alings, M., Amerena, J., Atar, D., Avezum, Á., Blomström, P., Borggrefe, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109867 · Cited by 628
The Effect of Warfarin and Intensity of Anticoagulation on Outcome of Intracerebral Hemorrhage
Rosand, J. M., Eckman, M. H., Knudsen, K. A., Singer, D. E., & Greenberg, S. M. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.8.880 · Cited by 617
Long-term Outcomes in Individuals With Prolonged PR Interval or First-Degree Atrioventricular Block
Cheng, S. (2009) · JAMA · doi:10.1001/jama.2009.888 · Cited by 614
Meta-analysis identifies six new susceptibility loci for atrial fibrillation
Ellinor, P. T., Lunetta, K. L., Albert, C. M., Glazer, N. L., Ritchie, M. D., Smith, A. V., Arking, D. E., Müller-Nurasyid, M., Krijthe, B. P., Lubitz, S. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2261 · Cited by 601
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
Hohnloser, S. H., Hijazi, Z., Thomas, L., Alexander, J. H., Amerena, J., Hanna, M., Keltai, M., Lanas, F., Lopes, R. D., Lopez-Sendon, J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs274 · Cited by 574
Genetic Determinants of Response to Warfarin during Initial Anticoagulation
Schwarz, U. I., Ritchie, M. D., Bradford, Y., Li, C., DUDEK, S. M., Frye-Anderson, A., Kim, R. B., Roden, D. M., & Stein, C. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708078 · Cited by 572
Predictors of Thromboembolism in Atrial Fibrillation: II. Echocardiographic Features of Patients at Risk
The Stroke Prevention in Atrial Fibrillation Investigators (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-6 · Cited by 546
Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation
Piccini, J. P., Stevens, S. R., Chang, Y., Singer, D. E., Lokhnygina, Y. V., Go, A. S., Patel, M. R., Mahaffey, K. W., Halperin, J. L., BREITHARDT, G. E., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.107128 · Cited by 503
Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control
Skanes, A. C., Healey, J. S., Cairns, J. A., Dorian, P., Gillis, A. M., McMurtry, M. S., Mitchell, L. B., Verma, A., & Nattel, S. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.01.021 · Cited by 493
A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke
Gudbjartsson, D. F., Holm, H., Gretarsdottir, S., Thorleifsson, G., Walters, G. B., Thorgeirsson, G., Gulcher, J., Mathiesen, E. B., Njølstad, I., Nyrnes, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.417 · Cited by 489
Echocardiographic Assessment of Myocardial Strain
Gorcsan, J., & Tanaka, H. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.038 · Cited by 488
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
Ruff, C. T., Giugliano, R. P., Antman, E. M., Crugnale, S. E., Bocanegra, T. S., Mercuri, M. F., HANYOK, J. J., Patel, I. J., Shi, M., Salazar, D., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.06.042 · Cited by 480
Outpatient treatment of recent-onset atrial fibrillation with the “Pill-in-the-Pocket” approach
Alboni, P., Botto, G. L., Baldi, N., Luzi, M., Russo, V., Gianfranchi, L., Marchi, P., Calzolari, M., Solano, A., Baroffio, R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041233 · Cited by 479
Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy
Hohnloser, S. H., Pajitnev, D., Pogue, J. M., Healey, J. S., Pfeffer, M. A., Yusuf, S., & Connolly, S. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.076 · Cited by 459
Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study
Friberg, L., Rosenqvist, M., & Lip, G. Y. H. (2012) · Circulation · doi:10.1161/circulationaha.111.055079 · Cited by 454
Self-citation
Electropathological Substrate of Long-Standing Persistent Atrial Fibrillation in Patients With Structural Heart Disease: Longitudinal Dissociation
Allessie, M. A., de Groot, N. M. S., Houben, R. P. M., Schotten, U., Boersma, E., Smeets, J. L., & Crijns, H. J. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.910125 · Cited by 450
Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation
Go, A. S., Fang, M. C., Udaltsova, N. V., Chang, Y., Pomernacki, N. K., Borowsky, L. H., & Singer, D. E. (2009) · Circulation · doi:10.1161/circulationaha.108.816082 · Cited by 447
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study
Lip, G., Lindhardsen, J., Lane, D., Ahlehoff, O., Hansen, M., Raunsø, J., Tolstrup, J., Hansen, P., Gislason, G., Torp-Pedersen, C., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0364 · Cited by 428
Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation
Hendriks, J. M. L., de Wit, R., Crijns, H. J. G. M., Vrijhoef, H. J. M., Prins, M. H., Pisters, R., Pison, L. A. F. G., Blaauw, Y., & Tieleman, R. G. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs071 · Cited by 409
Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy
Hijazi, Z., Oldgren, J., Andersson, U., Connolly, S. J., Ezekowitz, M. D., Hohnloser, S. H., Reilly, P. A., Vinereanu, D., Siegbahn, A., Yusuf, S., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.038729 · Cited by 402
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)
Wann, L. S., Curtis, A. B., Ellenbogen, K. A., Estes, N. A. M., Ezekowitz, M. D., Jackman, W. M., January, C. T., Lowe, J. E., Page, R. L., Slotwiner, D. J., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820f14c0 · Cited by 398
Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy
Maron, B. J., Olivotto, I., Bellone, P., Conte, M. R., Cecchi, F., Flygenring, B., Casey, S. A., Gohman, T. E., Bongioanni, S., & Spirito, P. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01727-2 · Cited by 396
Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography
Tsang, T. S. M., Barnes, M. E., Gersh, B. J., Takemoto, Y., Rosales, A. G., Bailey, K. R., & Seward, J. B. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00943-4 · Cited by 390
Excessive Supraventricular Ectopic Activity and Increased Risk of Atrial Fibrillation and Stroke
Binici, Z., Intzilakis, T., Nielsen, O. W., Køber, L., & Sajadieh, A. (2010) · Circulation · doi:10.1161/circulationaha.109.874982 · Cited by 379
Electropathological Substrate of Longstanding Persistent Atrial Fibrillation in Patients With Structural Heart Disease
de Groot, N. M. S., Houben, R. P. M., Smeets, J. L. R. M., Boersma, E. H., Schotten, U., Schalij, M. J., Crijns, H. J. G. M., & Allessie, M. A. (2010) · Circulation · doi:10.1161/circulationaha.109.910901 · Cited by 357
Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation
Apostolakis, S. Z., Lane, D. A., Guo, Y., Buller, H. R., & Lip, G. Y. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.019 · Cited by 356
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation
Rudolph, V., Andrié, R., Rudolph, T. K., Friedrichs, K. P., Klinke, A., Hirsch-Hoffmann, B., Schwoerer, A. P., Lau, D., Fu, X., Klingel, K., et al. (2010) · Nature Medicine · doi:10.1038/nm.2124 · Cited by 352
Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation
Conen, D. (2011) · JAMA · doi:10.1001/jama.2011.659 · Cited by 349
Detection of Pulmonary Vein and Left Atrial Scar after Catheter Ablation with Three-dimensional Navigator-gated Delayed Enhancement MR Imaging: Initial Experience1
Peters, D. C., Wylie, J. V., Hauser, T. H., Kissinger, K. V., Botnar, R. M., Essebag, V., Josephson, M. E., & Manning, W. J. (2007) · Radiology · doi:10.1148/radiol.2433060417 · Cited by 336
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial
FETSCH, T. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.04.015 · Cited by 334
Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: Implications for disease progression and response to catheter ablation
Mahnkopf, C., Badger, T. J., Burgon, N. S., Daccarett, M., Haslam, T. S., Badger, C. T., McGann, C. J., AKOUM, N. W., Kholmovski, E. G., MacLeod, R., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.06.030 · Cited by 334
Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study
Das, R. R., Seshadri, S., Beiser, A. S., Kelly-Hayes, M., Au, R., Himali, J. J., Kase, C. S., Benjamin, E. J., Polak, J. F., O'Donnell, C. J., et al. (2008) · Stroke · doi:10.1161/strokeaha.108.516575 · Cited by 324
Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification
Wang, J., Klysik, E. A., Sood, S., Johnson, R. L., Wehrens, X. H. T., & Martin, J. F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912585107 · Cited by 323
PITX2c Is Expressed in the Adult Left Atrium, and Reducing Pitx2c Expression Promotes Atrial Fibrillation Inducibility and Complex Changes in Gene Expression
Kirchhof, P. F., Kahr, P. C., Kaese, S., Piccini, I., Vokshi, I., Scheld, H. H., Rotering, H., Fortmueller, L., Laakmann, S., Verheule, S., et al. (2011) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.958058 · Cited by 319
Noninvasive Characterization of Epicardial Activation in Humans With Diverse Atrial Fibrillation Patterns
Cuculich, P. S., Wang, Y., Lindsay, B. D., Faddis, M. N., Schuessler, R. B., Damiano, R. J., Li, L., & Rudy, Y. (2010) · Circulation · doi:10.1161/circulationaha.110.945709 · Cited by 311
Major bleeding during anticoagulation after cerebral ischemia
Gorter, J. W., (SPIRIT), F. T. S. P. I. R. I. T., & Groups, E. A. F. T. (. S. (1999) · Neurology · doi:10.1212/wnl.53.6.1319 · Cited by 307
Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study
Mm, B. (1994) · JAMA · doi:10.1001/jama.272.1.33 · Cited by 304
Echocardiographic Predictors of Stroke in Patients With Atrial Fibrillation
Atrial Fibrillation Investigators: Atrial Fibrillation, A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.12.1316 · Cited by 302
Influence of Blood Pressure on Left Atrial Size
Vaziri, S. M., Larson, M. G., Lauer, M. S., Benjamin, E. J., & Levy, D. A. (1995) · Hypertension · doi:10.1161/01.hyp.25.6.1155 · Cited by 298
Biomarkers in atrial fibrillation: a clinical review
Hijazi, Z., Oldgren, J., Siegbahn, A., Granger, C. B., & Wallentin, L. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht024 · Cited by 298
Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association
Kirchhof, P., Auricchio, A., Bax, J., Crijns, H., Camm, J., Diener, H.-C., Goette, A., Hindricks, G., Hohnloser, S., Kappenberger, L., et al. (2007) · Europace · doi:10.1093/europace/eum191 · Cited by 293
Relations of Biomarkers of Distinct Pathophysiological Pathways and Atrial Fibrillation Incidence in the Community
Schnabel, R. B., Larson, M. G., Yamamoto, J. F., SULLIVAN, L. M., Pencina, M. J., Meigs, J. B., Tofler, G. H., Selhub, J., Jacques, P. F., Wolf, P. A., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.882241 · Cited by 290
Atrial fibrillation and incidence of dementia
Kwok, C. S., Loke, Y. K., Hale, R., Potter, J. F., & Myint, P. K. (2011) · Neurology · doi:10.1212/wnl.0b013e31820f2e38 · Cited by 286
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation
Nieuwlaat, R., Prins, M. H., Heuzey, J. Y. L., Vardas, P. E., Aliot, E., Santini, M., Cobbe, S. M., Widdershoven, J. W. M. G., Baur, L. H. B., Lévy, S., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn139 · Cited by 283
Atrial fibrillation and the risk of incident dementia: A meta-analysis
Santangeli, P., Biase, L. D., Bai, R., Mohanty, S., Pump, A., Brantes, M. C., Horton, R., Burkhardt, J. D., Lakkireddy, D., Reddy, Y. M., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.07.026 · Cited by 282
Antithrombotic Drug Use, Cerebral Microbleeds, and Intracerebral Hemorrhage
Lovelock, C. E., Cordonnier, C., Naka, H., Salman, R. A., Sudlow, C. L. M., The Edinburgh Stroke Study Group, Sorimachi, T., Werring, D. J., Gregoire, S. M., Imaizumi, T., et al. (2010) · Stroke · doi:10.1161/strokeaha.109.572594 · Cited by 277
A Randomized Active-Controlled Study Comparing the Efficacy and Safety of Vernakalant to Amiodarone in Recent-Onset Atrial Fibrillation
Camm, A. J., Capucci, A., Hohnloser, S. H., Torp-Pedersen, C. T., Gelder, I. C. V., Mangal, B., & Beatch, G. N. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.046 · Cited by 276
Effect of Simvastatin and Antioxidant Vitamins on Atrial Fibrillation Promotion by Atrial-Tachycardia Remodeling in Dogs
Shiroshita-Takeshita, A., Schram, G., Lavoie, J., & Nattel, S. (2004) · Circulation · doi:10.1161/01.cir.0000145163.56529.d1 · Cited by 274
Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation
Conway, D., Pearce, L. A., Chin, B., Hart, R. G., & Lip, G. Y. H. (2003) · Circulation · doi:10.1161/01.cir.0000077912.12202.fc · Cited by 269
Association Between C-Reactive Protein and Recurrence of Atrial Fibrillation After Successful Electrical Cardioversion
Liu, T., Li, G., Li, L., & Korantzopoulos, P. G. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.12.042 · Cited by 268
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options—a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference
Kirchhof, P. F., Lip, G. Y. H., Gelder, I. C. V., Bax, J. J., Hylek, E. M., Kääb, S., Schotten, U., Wegscheider, K., Boriani, G., Brandes, A., et al. (2011) · EP Europace · doi:10.1093/europace/eur241 · Cited by 247
Association of Chronic Kidney Disease With Atrial Fibrillation Among Adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study
Baber, U., Howard, V. J., Halperin, J. L., Soliman, E. Z., Zhang, X., McClellan, W., Warnock, D. G., & Muntner, P. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.110.957100 · Cited by 247
Fibrin d -Dimer and β-Thromboglobulin as Markers of Thrombogenesis and Platelet Activation in Atrial Fibrillation
Lip, G. Y. H., Lip, P. L., Zarifis, J., Watson, R. D., Bareford, D., Lowe, G. D. O., & Beevers, D. G. (1996) · Circulation · doi:10.1161/01.cir.94.3.425 · Cited by 246
Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies
Marzona, I., O'Donnell, M. J., Teo, K. K., Gao, P., Anderson, C. S., Bosch, J., & Yusuf, S. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.111173 · Cited by 246
Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review
Pugh, D., Pugh, J., & Mead, G. E. (2011) · Age and Ageing · doi:10.1093/ageing/afr097 · Cited by 243
Real-Time 3D Echocardiographic Quantification of Left Atrial Volume
Mor‐Avi, V., Yodwut, C., Jenkins, C., Kühl, H. P., Nesser, H., Marwick, T. H., Franke, A., Weinert, L., Niel, J., Steringer‐Mascherbauer, R., et al. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.05.011 · Cited by 241
Clinical Utility of Multimodality LA Imaging
To, A. C. Y., Flamm, S. D., Marwick, T. H., & Klein, A. L. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.02.018 · Cited by 237
Stepwise Screening of Atrial Fibrillation in a 75-Year-Old Population: Implications for Stroke Prevention
Engdahl, J., Andersson, L., Mirskaya, M., & Rosenqvist, M. (2013) · Circulation · doi:10.1161/circulationaha.112.126656 · Cited by 233
Fish Oil and Postoperative Atrial Fibrillation
Mozaffarian, D., Marchioli, R., Macchia, A., Silletta, M. G., Ferrazzi, P., Gardner, T. J., Latini, R., Libby, P., Lombardi, F., O’Gara, P. T., et al. (2012) · JAMA · doi:10.1001/jama.2012.28733 · Cited by 230
Cerebral Microbleeds and Recurrent Stroke Risk
Charidimou, A., Kakar, P., Fox, Z. V., & Werring, D. J. (2013) · Stroke · doi:10.1161/strokeaha.111.000038 · Cited by 226
Left Atrial Strain Predicts Reverse Remodeling After Catheter Ablation for Atrial Fibrillation
Tops, L. F., Delgado, V., Bertini, M., Marsan, N. A., den Uijl, D. W., Trines, S. A. I. P., Zeppenfeld, K., Holman, E. R., Schalij, M. J., & Bax, J. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.063 · Cited by 225
Atrial Fibrillation and the Risk of Sudden Cardiac Death
Chen, L. Y., Sotoodehnia, N., Bůžková, P., Norby, F. L., Yee, L. M., Heckbert, S. R., Prineas, R. J., Soliman, E. Z., Adabağ, S., Konety, S., et al. (2012) · JAMA Internal Medicine · doi:10.1001/2013.jamainternmed.744 · Cited by 224
Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment
Gerdts, E., Wachtell, K., Omvik, P., Otterstad, J. E., Oikarinen, L., Boman, K., Dahlöf, B., & Devereux, R. B. (2006) · Hypertension · doi:10.1161/01.hyp.0000254322.96189.85 · Cited by 222
Chromosome 4q25 Variants and Atrial Fibrillation Recurrence After Catheter Ablation
Husser, D., Adams, V., Piorkowski, C., Hindricks, G., & Bollmann, A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.041 · Cited by 218
Evaluation of Left Atrial Lesions After Initial and Repeat Atrial Fibrillation Ablation
Badger, T. J., Daccarett, M., AKOUM, N. W., Adjei-Poku, Y. A., Burgon, N. S., Haslam, T. S., Kalvaitis, S., Kuppahally, S. S., Vergara, G., McMullen, L., et al. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.868356 · Cited by 213
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial
Lópes, R. D., Al‐Khatib, S. M., Wallentin, L. C., Yang, H., Ansell, J., Bahit, M. C., Caterina, R. D., Dorian, P., Easton, J. D., Erol, Ç., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60986-6 · Cited by 210
Effect of Single-Drug Therapy on Reduction of Left Atrial Size in Mild to Moderate Hypertension
Gottdiener, J. S., Reda, D. J., Williams, D. W., Materson, B. J., Cushman, W. G., & Anderson, R. J. (1998) · Circulation · doi:10.1161/01.cir.98.2.140 · Cited by 203
Subtle Post-Procedural Cognitive Dysfunction After Atrial Fibrillation Ablation
MEDI, C., Evered, L. A., SILBERT, B. S., Teh, A. W., Halloran, K., Morton, J. B., Kistler, P. M., & Kalman, J. M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.073 · Cited by 190
Occult Atrial Fibrillation in Cryptogenic Stroke
Ritter, M., Kochhäuser, S., Duning, T., Reinke, F., Pott, C., Dechering, D. G., Eckardt, L., & Ringelstein, E. B. (2013) · Stroke · doi:10.1161/strokeaha.111.676189 · Cited by 180
Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial
Kirchhof, P., Andresen, D., Bosch, R., Borggrefe, M., Meinertz, T., Parade, U., Ravens, U., Samol, A., Steinbeck, G., Treszl, A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60570-4 · Cited by 176
Frailty and its quantitative clinical evaluation
Moorhouse, P. A., & Rockwood, K. J. (2012) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2012.412 · Cited by 175
Omega-3 Fatty Acid Supplementation Does Not Reduce Risk of Atrial Fibrillation After Coronary Artery Bypass Surgery
Saravanan, P., Bridgewater, B., West, A. L., O'Neill, S. C., Calder, P. C., & Davidson, N. C. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.899633 · Cited by 172
Frequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events
Chong, B.-H., Pong, V., Lam, K., Liu, S., Zuo, M., Lau, Y.-F., LAU, C., Tse, H.-F., & Siu, C. (2011) · EP Europace · doi:10.1093/europace/eur389 · Cited by 161
Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study
O'Donnell, M. J., Oczkowski, W., Fang, J., Kearon, C., Silva, J. R., Bradley, C., Guyatt, G. H., Gould, L., D'Uva, C., Kapral, M. K., et al. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70536-1 · Cited by 161
Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries
Spall, H. G. C. V., Wallentin, L. C., Yusuf, S., Eikelboom, J. W., Nieuwlaat, R., Yang, S., Kabali, C., Reilly, P. A., Ezekowitz, M. D., & Connolly, S. J. (2012) · Circulation · doi:10.1161/circulationaha.112.101808 · Cited by 157
Suppression of paroxysmal atrial tachyarrhythmias—results of the SOPAT trial
PATTEN, M., MAAS, R., BAUER, P., LUDERITZ, B., SONNTAG, F., DLUZNIEWSKI, M., HATALA, R., OPOLSKI, G., MULLER, H., & MEINERTZ, T. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.014 · Cited by 157
Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation
de Vos, C. B., Weijs, B., Crijns, H. J. G. M., Cheriex, E. C., Palmans, A., Habets, J., Prins, M. H., Pisters, R., Nieuwlaat, R., & Tieleman, R. G. (2008) · Heart · doi:10.1136/hrt.2008.148528 · Cited by 157
Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial
Kirchhof, P., Breithardt, G., Camm, A. J., Crijns, H. J., Kuck, K.-H., Vardas, P., & Wegscheider, K. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.05.015 · Cited by 155
Time course and mechanisms of endo-epicardial electrical dissociation during atrial fibrillation in the goat
Eckstein, J., Maesen, B. A. E., Linz, D., Zeemering, S., van Hunnik, A., Verheule, S., Allessie, M. A., & Schotten, U. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq336 · Cited by 154
Atrial fibrillation and the risk of cerebral white matter lesions
de Leeuw, F., de Groot, J. C., Oudkerk, M., Kors, J. A., Albert Hofman, D., van Gijn, J., & Breteler, M. M. B. (2000) · Neurology · doi:10.1212/wnl.54.9.1795 · Cited by 153
Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey
Pisters, R., Nieuwlaat, R., Prins, M. H., Heuzey, J. Y. L., Maggioni, A. P., Camm, A. J., Crijns, H. J. G. M., & for the Euro Heart Survey Investigators (2012) · EP Europace · doi:10.1093/europace/eur406 · Cited by 152
High Sensitivity C-Reactive Protein
Malouf, J. F., Kanagala, R., Alatawi, F. O., Rosales, A. G., Davison, D. E., Murali, N. S., Tsang, T. S. M., Chandrasekaran, K., Ammash, N. M., Friedman, P. A., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.053 · Cited by 143
Association of Plasma Phospholipid Long-Chain Omega-3 Fatty Acids With Incident Atrial Fibrillation in Older Adults
Wu, J. H. Y., Lemaître, R. N., King, I. B., Song, X., Sacks, F. M., Rimm, E. B., Heckbert, S. R., Siscovick, D. S., & Mozaffarian, D. (2012) · Circulation · doi:10.1161/circulationaha.111.062653 · Cited by 143
Echocardiographic left atrial reverse remodeling after catheter ablation of atrial fibrillation is predicted by preablation delayed enhancement of left atrium by magnetic resonance imaging
Kuppahally, S. S., AKOUM, N. W., Badger, T. J., Burgon, N. S., Haslam, T. S., Kholmovski, E. G., MacLeod, R., McGann, C. J., & MARROUCHE, N. F. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.07.003 · Cited by 143
Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria
Eckstein, J., Verheule, S., de Groot, N. M. S., Allessie, M. A., & Schotten, U. (2008) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2008.02.019 · Cited by 141
Symptomatic Response to Antiarrhythmic Drug Therapy Is Modulated by a Common Single Nucleotide Polymorphism in Atrial Fibrillation
Parvez, B., Vaglio, J. C., Rowan, S. B., Muhammad, R., Kucera, G., Stubblefield, T., Carter, S., Roden, D. M., & Darbar, D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.070 · Cited by 141
COL4A1 mutations in patients with sporadic late‐onset intracerebral hemorrhage
Weng, Y., Sonni, A., Labelle‐Dumais, C., de Leau, M., Kauffman, W. B., Jeanne, M., Biffi, A., Greenberg, S. M., Rosand, J. M., & Gould, D. B. (2011) · Annals of Neurology · doi:10.1002/ana.22682 · Cited by 139
Plasma B-Type Natriuretic Peptide Levels and Recurrent Arrhythmia After Successful Ablation of Lone Atrial Fibrillation
Hussein, A. A., Saliba, W. I., Martin, D. O., Shadman, M. S., Kanj, M. H., Bhargava, M., Dresing, T., Chung, M. K., Callahan, T. D., Baranowski, B. J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.007252 · Cited by 138
Atrial Fibrosis Quantified Using Late Gadolinium Enhancement MRI is Associated With Sinus Node Dysfunction Requiring Pacemaker Implant
AKOUM, N. W., McGann, C. J., VERGARA, G., Badger, T. J., Ranjan, R., Mahnkopf, C., Kholmovski, E. G., MacLeod, R., & MARROUCHE, N. F. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02140.x · Cited by 138
Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): Design and rationale
Sinha, A. M., Diener, H., Morillo, C. A., Sanna, T., Bernstein, R. A., Lazzaro, V. D., PASSMAN, R. S., Beckers, F., & Brachmann, J. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.03.032 · Cited by 134
Left atrial enlargement. Echocardiographic assessment of electrocardiographic criteria.
Waggoner, A. D., Adyanthaya, A. V., Quiñones, M. A., & Alexander, J. K. (1976) · Circulation · doi:10.1161/01.cir.54.4.553 · Cited by 127
Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation
Habara, S., Dote, K., Kato, M., Sasaki, S., Goto, K., Takemoto, H., Hasegawa, D., & Matsuda, O. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm356 · Cited by 123
Changes in left and right atrial size after cardioversion of atrial fibrillation: Role of mitral valve disease
Gosselink, A. T. M., Crijns, H. J. G. M., Hamer, H. P. M., Hillege, H. L., & Lie, K. I. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90593-p · Cited by 120
Variation in the 4q25 Chromosomal Locus Predicts Atrial Fibrillation After Coronary Artery Bypass Graft Surgery
Body, S. C., Collard, C. D., Shernan, S. K., Fox, A. A., Liu, K.-Y., Ritchie, M. D., Perry, T. E., Muehlschlegel, J. D., Aranki, S. F., Donahue, B. S., et al. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.849075 · Cited by 119
Renal Impairment and Ischemic Stroke Risk Assessment in Patients With Atrial Fibrillation
Banerjee, A., Fauchier, L., Vourc’h, P., Andres, C. R., Taillandier, S., Halimi, J., & Lip, G. Y. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.035 · Cited by 116
Comparison of Left Atrial Volumes and Function by Real-Time Three-Dimensional Echocardiography in Patients Having Catheter Ablation for Atrial Fibrillation With Persistence of Sinus Rhythm Versus Recurrent Atrial Fibrillation Three Months Later
Marsan, N. A., Tops, L. F., Holman, E. R., de Veire, N. R. V., Zeppenfeld, K., Boersma, E. H., van der Wall, E. E., Schalij, M. J., & Bax, J. J. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.05.048 · Cited by 114
Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?
Heidarsdottir, R., Arnar, D. O., Skúladóttir, G. V., Torfason, B., Edvardsson, V. O., Gottskálksson, G., Pálsson, R., & Indridason, Ó. S. (2010) · EP Europace · doi:10.1093/europace/eup429 · Cited by 113
The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation
Kallergis, E. M., Manios, E. G., Kanoupakis, E. M., Mavrakis, H. E., Kolyvaki, S., Lyrarakis, G., Chlouverakis, G., & Vardas, P. E. (2007) · Heart · doi:10.1136/hrt.2006.108688 · Cited by 113
[The effect of dronedarone on the frequency of cardiovascular events in patients with atrial fibrillation - ATHENA studies].
Pikto−Pietkiewicz, W. (2009) · PubMed · Cited by 113
Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease
Schmidt, H., Zeginigg, M., Wiltgen, M., Freudenberger, P., Petrovic, K., Cavalieri, M., Gider, P., Enzinger, C., Fornage, M., Debette, S., et al. (2011) · Brain · doi:10.1093/brain/awr252 · Cited by 112
Giant T–U Waves Precede Torsades de Pointes in Long QT Syndrome
Kirchhof, P., Franz, M. R., Bardai, A., & Wilde, A. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.043 · Cited by 112
Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'
Kirchhof, P. F., Bax, J. J., Blomstrom-Lundquist, C., Calkins, H., Camm, A. J., Cappato, R., Cosío, F. G., Crijns, H. J. G. M., Diener, H., Goette, A., et al. (2009) · EP Europace · doi:10.1093/europace/eup124 · Cited by 112
Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
Roldán, V., Marín, F. R., Manzano‐Fernández, S., Fernández, H., Gallego, P., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-01-0054 · Cited by 111
Amino Terminal Pro–B-Type Natriuretic Peptide, Secondary Stroke Prevention, and Choice of Antithrombotic Therapy
Longstreth, W. T., Kronmal, R. A., Thompson, J. L. P., Christenson, R. H., Levine, S. R., Gross, R., Brey, R. L., Buchsbaum, R., Elkind, M. S. V., Tirschwell, D., et al. (2013) · Stroke · doi:10.1161/strokeaha.112.675942 · Cited by 111
Myocardial Redox State Predicts In-Hospital Clinical Outcome After Cardiac Surgery
Antoniades, C. A., Demosthenous, M., Reilly, S. N., Margaritis, M., Zhang, M., Antonopoulos, A. S., Marinou, K., Nahar, K., Jayaram, R., Tousoulis, D., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.062 · Cited by 110
Ejection Fraction and Outcomes in Patients with Atrial Fibrillation and Heart Failure: The Loire Valley Atrial Fibrillation Project
Banerjee, A., Taillandier, S., Olesen, J. B., Lane, D. A., Lallemand, B., Lip, G. Y. H., & Fauchier, L. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs005 · Cited by 109
High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation
Roldán, V., Marín, F. R., DÍAZ, J., Gallego, P., Jover, E., Romera, M., Manzano‐Fernández, S., Casas, T., Valdés, M., Vicente, V., et al. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04812.x · Cited by 108
D-dimer level influences thromboembolic events in patients with atrial fibrillation
Nozawa, T., Inoue, H., Hirai, T., Iwasa, A., Okumura, K., Lee, J., Shimizu, A., Hayano, M., & Yano, K. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.05.049 · Cited by 107
Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort
Ip, J. E., Waldo, A. L., Lip, G. Y. H., Rothwell, P. M., Martin, D. T., BERSOHN, M. M., Choucair, W. K., Akar, J. G., Wathen, M. S., Rohani, P., et al. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.07.002 · Cited by 106
Fibrillatory Conduction in the Atrial Free Walls of Goats in Persistent and Permanent Atrial Fibrillation
Verheule, S., Tuyls, E., van Hunnik, A., Kuiper, M., Schotten, U., & Allessie, M. A. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.931634 · Cited by 106
Evidence That D-Dimer Levels Predict Subsequent Thromboembolic and Cardiovascular Events in Patients With Atrial Fibrillation During Oral Anticoagulant Therapy
Sadanaga, T., Sadanaga, M., & Ogawa, S. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.049 · Cited by 105
Impact of Biomarkers of Inflammation and Extracellular Matrix Turnover on the Outcome of Atrial Fibrillation Ablation: Importance of Matrix Metalloproteinase-2 as a Predictor of Atrial Fibrillation Recurrence
Okumura, Y., Watanabe, I., Nakai, T., Ohkubo, K., Kofune, T., Kofune, M., Nagashima, K., Mano, H., Sonoda, K., Kasamaki, Y., et al. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02059.x · Cited by 103
Systematic Analysis of Gene Expression Differences between Left and Right Atria in Different Mouse Strains and in Human Atrial Tissue
Kahr, P. C., Piccini, I., Fabritz, L., Greber, B., Schöler, H. R., Scheld, H. H., Hoffmeier, A., Brown, N. A., & Kirchhof, P. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026389 · Cited by 103
Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation
Richter, B., Gwechenberger, M., Socas, A. G., Zorn, G., Albinni, S., Marx, M., Bergler-Klein, J. K., Binder, T. M., Wojta, J., & Gössinger, H. (2011) · Clinical Research in Cardiology · doi:10.1007/s00392-011-0383-3 · Cited by 102
Extracellular Matrix Alterations in Patients With Paroxysmal and Persistent Atrial Fibrillation
Kallergis, E. M., Manios, E. G., KANOUPAKIS, E. M., Mavrakis, H. E., Arfanakis, D. A., Maliaraki, N. E., Lathourakis, C. E., CHLOUVERAKIS, G. I., & Vardas, P. E. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.045 · Cited by 101
Genetic variation at CR1 increases risk of cerebral amyloid angiopathy
Biffi, A., Shulman, J. M., Jagiella, J. M., Cortellini, L., Ayres, A. M., Schwab, K. M., Brown, D. L., Silliman, S. L., Selim, M. H., Worrall, B. B., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182452b40 · Cited by 99
3 Tesla MRI‐Detected Brain Lesions after Pulmonary Vein Isolation for Atrial Fibrillation: Results of the MACPAF Study
Hæusler, K. G., Koch, L., Herm, J., Kopp, U. A., Heuschmann, P. U., Endres, M., Schultheiss, H.-P., Schirdewan, A., & Fiebach, J. B. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2012.02420.x · Cited by 98
Cerebral Microbleeds on Magnetic Resonance Imaging and Anticoagulant-Associated Intracerebral Hemorrhage Risk
Charidimou, A., Shakeshaft, C., & Werring, D. J. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00133 · Cited by 98
MRI of left ventricular function
Epstein, F. H. (2007) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2007.07.006 · Cited by 95
A Common β1-Adrenergic Receptor Polymorphism Predicts Favorable Response to Rate-Control Therapy in Atrial Fibrillation
Parvez, B., Chopra, N., Rowan, S. B., Vaglio, J. C., Muhammad, R., Roden, D. M., & Darbar, D. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.061 · Cited by 94
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists
Lip, G. Y. H., Rasmussen, L. H., Olsson, S., Jensen, E. C., Persson, A., Eriksson, U. G., & Wåhlander, K. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp318 · Cited by 94
A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA)
Kirchhof, P. F., Mönnig, G., Wasmer, K., Heinecke, A., BREITHARDT, G. E., Eckardt, L., & Böcker, D. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi160 · Cited by 93
Detection of Asymptomatic Cerebral Microbleeds
Stehling, C., Wersching, H., Kloska, S. P., Kirchhof, P. F., Ring, J., Naßenstein, I., Allkemper, T., Knecht, S., Bachmann, R., & Heindel, W. L. (2008) · Academic Radiology · doi:10.1016/j.acra.2008.01.013 · Cited by 93
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options
Lip, G. Y. H., Gelder, I. C. V., Bax, J. J., Hylek, E. M., Kääb, S., Schotten, U., Wegscheider, K., Boriani, G., Ezekowitz, M. D., Diener, H. C., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-07-0517 · Cited by 91
Apolipoprotein E Genotype Predicts Hematoma Expansion in Lobar Intracerebral Hemorrhage
Brouwers, H. B., Biffi, A., Ayres, A. M., Schwab, K. M., Cortellini, L., Romero, J. M., Rost, N. S., Viswanathan, A., Greenberg, S. M., Rosand, J. M., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.643262 · Cited by 89
Atrial and Ventricular Volume and Function Evaluated by Magnetic Resonance Imaging in Patients With Persistent Atrial Fibrillation Before and After Cardioversion
Therkelsen, S. K., Groenning, B. A., Svendsen, J. H., & Jensen, G. B. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.040 · Cited by 86
Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study
Turakhia, M. P., Hoang, D. D., Xu, X., Frayne, S. M., Schmitt, S. K., Yang, F., Phibbs, C. S., Than, C. T., Wang, P. J., & Heidenreich, P. A. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.10.010 · Cited by 84
Atrial fibrillation guidelines across the Atlantic: a comparison of the current recommendations of the European Society of Cardiology/European Heart Rhythm Association/European Association of Cardiothoracic Surgeons, the American College of Cardiology Foundation/American Heart Association/Heart Rhythm Society, and the Canadian Cardiovascular Society
Kirchhof, P. F., Curtis, A. B., Skanes, A. C., Gillis, A. M., Wann, L. S., & Camm, A. J. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs446 · Cited by 80
Silent brain infarction in nonrheumatic atrial fibrillation
Rubio Borrego, F. R. (1996) · Neurology · doi:10.1212/wnl.46.1.159 · Cited by 79
P Wave Signal‐Averaged Electrocardiography to Identify Risk for Atrial Fibrillation
Darbar, D., Jahangir, A., Hammill, S. C., & Gersh, B. J. (2002) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2002.01447.x · Cited by 78
A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice
Berti, D., Hendriks, J., Brandes, A., Deaton, C., Crijns, H. J. G. M., Camm, A. J., Hindricks, G., Moons, P., & Heidbüchel, H. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht096 · Cited by 78
Microembolism and Catheter Ablation II
Haines, D. E., Stewart, M. T., Barka, N., Kirchhof, N., Lentz, L. R., Reinking, N., Urban, J. F., Halimi, F., Deneke, T., & Kanal, E. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.973461 · Cited by 77
Left atrial catheter ablation and ischemic stroke
Haeusler, K. G., Kirchhof, P., & Endres, M. (2012) · Stroke · doi:10.1161/strokeaha.111.627067 · Cited by 77
Silent Cerebral Infarcts and Cerebral White Matter Lesions in Patients with Nonvalvular Atrial Fibrillation
Kobayashi, A., Iguchi, M., Shimizu, S., & Uchiyama, S. (2010) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2010.09.004 · Cited by 76
Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-Atrial Fibrillation Trial
Latini, R., Masson, S., Pirelli, S., Barlera, S., Pulitanò, G., Carbonieri, E., Gulizia, M. M., Vago, T., Favero, C., Zdunek, D., et al. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02287.x · Cited by 74
Comparison of probability of stroke between the Copenhagen City Heart Study and the Framingham Study.
Truelsen, T. C., Lindenstrøm, E., & Boysen, G. (1994) · Stroke · doi:10.1161/01.str.25.4.802 · Cited by 74
Noninvasive Mapping of Human Atrial Fibrillation
Guillem, M. S., Climent, A. M., Castells, F., Husser, D., Millet, J., Arya, A., Piorkowski, C., & Bollmann, A. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01356.x · Cited by 72
Relation of C-Reactive Protein to Long-Term Risk of Recurrence of Atrial Fibrillation After Electrical Cardioversion
Loricchio, M. L., Cianfrocca, C., Pasceri, V., Bianconi, L., Auriti, A., Calò, L., Lamberti, F., Castro, A., Pandozi, C., Palamara, A., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.12.074 · Cited by 71
Impact of the type of centre on management of AF patients: Surprising evidence for differences in antithrombotic therapy decisions
Gerth, A., Limbourg, T., Lewalter, T., Goette, A., Wegscheider, K., Treszl, A., Meinertz, T., Oeff, M., Ravens, U., BREITHARDT, G. E., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-02-0070 · Cited by 70
Systematic Review and Meta-analysis of the Efficacy of Cardioversion by Vernakalant and Comparators in Patients with Atrial Fibrillation
Bash, L. D., Buono, J. L., Davies, G., Martin, A., Fahrbach, K. R., Phatak, H. M., Avetisyan, R., & Mwamburi, M. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6374-4 · Cited by 66
Fibrin D-Dimer, Tissue-Type Plasminogen Activator, von Willebrand Factor, and Risk of Incident Stroke in Older Men
Wannamethee, S. G., Whincup, P. H., LENNON, L. T., Rumley, A., & Lowe, G. D. O. (2012) · Stroke · doi:10.1161/strokeaha.111.636373 · Cited by 66
Whole Genome Expression Differences in Human Left and Right Atria Ascertained by RNA Sequencing
Hsu, J., Hanna, P., Wagoner, D. R. V., Barnard, J., Serre, D., Chung, M. K., & Smith, J. D. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.961631 · Cited by 62
Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study
Lip, G. Y. H., Rasmussen, L. H., Skjøth, F., Overvad, K., & Larsen, T. B. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-000975 · Cited by 62
Hemodynamics and Echocardiograms Before and After Cardioversion of Atrial Fibrillation to Normal Sinus Rhythm
Orlando, J. R., van Herick, R., Aronow, W. S., & Olson, H. G. (1979) · CHEST Journal · doi:10.1378/chest.76.5.521 · Cited by 61
Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions
Sacher, F., Corcuff, J., Schraub, P., Bouffos, V. L., Georges, A., Jones, S., Lafitte, S., Bordachar, P., Hocini, M., Clémenty, J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm577 · Cited by 58
The electroanatomical remodelling of the left atrium is related to CHADS2/CHA2DS2VASc score and events of stroke in patients with atrial fibrillation
Park, J. H., Joung, B., Son, N., Shim, J. M., Lee, M., Hwang, C., & Pak, H. (2011) · EP Europace · doi:10.1093/europace/eur135 · Cited by 57
Silent cerebral infarcts and cerebral white matter lesions in patients with nonvalvular atrial fibrillation
小林, 晶. (2010) · Institutional Repositories DataBase (IRDB) · Cited by 57
Left Atrial Enlargement
Levin, A. R., Frand, M., & Baltaxe, H. A. (1972) · Radiology · doi:10.1148/104.3.615 · Cited by 56
Factors Associated With 90-Day Death After Emergency Department Discharge for Atrial Fibrillation
Atzema, C. L., Austin, P. C., Chong, A. S., & Dorian, P. (2013) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2012.12.022 · Cited by 55
Imaging and atrial fibrillation: the role of multimodality imaging in patient evaluation and management of atrial fibrillation
Tops, L. F., Schalij, M. J., & Bax, J. J. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq005 · Cited by 55
Atrial fibrillation detection using a smart phone
Lee, J., Reyes, B. A., McManus, D. D., Mathias, O., & Chon, K. H. (2012) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2012.6346146 · Cited by 53
Natriuretic peptide levels predict recurrence of atrial fibrillation after radiofrequency catheter ablation
den Uijl, D. W., Delgado, V., Tops, L. F., Ng, A. C. T., Boersma, E. H., Trines, S. A. I. P., Zeppenfeld, K., Schalij, M. J., van der Laarse, A., & Bax, J. J. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.09.031 · Cited by 47
P-wave signal averaging identifies patients prone to alcohol-induced paroxysmal atrial fibrillation
STEINBIGLER, P., Haberl, R., König, B., & Steinbeck, G. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03258-7 · Cited by 46
Left ventricular mass predicts left atrial appendage thrombus in persistent atrial fibrillation
Boyd, A. C., McKay, T., Nasibi, S., Richards, D. A. B., & Thomas, L. (2012) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jes153 · Cited by 44
Usefulness of Single Nucleotide Polymorphism in Chromosome 4q25 to Predict In-Hospital and Long-Term Development of Atrial Fibrillation and Survival in Patients Undergoing Coronary Artery Bypass Grafting
Virani, S. S., Brautbar, A., Lee, V., Elayda, M. A., Sami, S., Nambi, V., Frazier, L. Q., Wilson, J. M., Willerson, J. T., Boerwinkle, E., et al. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.01.026 · Cited by 42
Prediction of Atrial Fibrillation in Patients with an Implantable Cardioverter-Defibrillator and Heart Failure
Bertini, M., Borleffs, C. J. W., Delgado, V., Ng, A. C. T., Piers, S. R. D., Shanks, M., Antoni, M. L., Biffi, M., Boriani, G., Schalij, M. J., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq126 · Cited by 42
Higher Degree of Left Atrial Structural Remodeling in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction
Akkaya, M., Higuchi, K., Koopmann, M., Damal, K., Burgon, N. S., Kholmovski, E. G., McGann, C. J., & MARROUCHE, N. F. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12090 · Cited by 41
Clinical and echocardiographic correlates of intra-atrial conduction delay
Weijs, B., de Vos, C. B., Tieleman, R. G., Pisters, R., Cheriex, E. C., Prins, M. H., & Crijns, H. J. G. M. (2011) · EP Europace · doi:10.1093/europace/eur261 · Cited by 41

Flagged first, then by citations

Research works printed but not linked: 6

2012, 2012, 1177
Bikkina, 1994, JAMA, 272, 33, 10.1001/jama.1994.03520010045030 · DOI
Lechleitner, 1991, Zeitschrift f r Kardiologie, 80, 574
Liakopoulos, 2012, Cochrane database of systematic reviews (Online), 4, CD008493
2009, Circulation: Arrhythmia and Electrophysiology, 3, 46
2012, Europace, 14, 8, 10.1093/europace/eur241 · DOI

Sorted by citations

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)
Task Force Members, Lip, G. Y. H., Windecker, S., Huber, K., Kirchhof, P. F., Marín, F. R., ten Berg, J. M., Hæusler, K. G., Boriani, G., Capodanno, D., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu298 · Cited by 573
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
Hijazi, Z., Oldgren, J., Lindbäck, J., Alexander, J. H., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Held, C., Hylek, E. M., Lopes, R. D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00741-8 · Cited by 490

See all 141

Authors: Kirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., Bailleul, C., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., Boersma, L., Boriani, G., Brandes, A., Brown, H., Brueckmann, M., Calkins, H., Casadei, B., Clemens, A., Crijns, H., Derwand, R., Dobrev, D., Ezekowitz, M., Fetsch, T., Gerth, A., Gillis, A., Gulizia, M., Hack, G., Haegeli, L., Hatem, S., Georg Hausler, K., Heidbuchel, H., Hernandez-Brichis, J., Jais, P., Kappenberger, L., Kautzner, J., Kim, S., Kuck, K.-H., Lane, D., Leute, A., Lewalter, T., Meyer, R., Mont, L., Moses, G., Mueller, M., Munzel, F., Nabauer, M., Nielsen, J. C., Oeff, M., Oto, A., Pieske, B., Pisters, R., Potpara, T., Rasmussen, L., Ravens, U., Reiffel, J., Richard-Lordereau, I., Schafer, H., Schotten, U., Stegink, W., Stein, K., Steinbeck, G., Szumowski, L., Tavazzi, L., Themistoclakis, S., Thomitzek, K., Van Gelder, I. C., von Stritzky, B., Vincent, A., Werring, D., Willems, S., Lip, G. Y. H., & Camm, A. J.
Affiliations: University Hospital Münster (DE)
Centre Hospitalier Régional et Universitaire de Nancy (FR)
University of Birmingham (GB)
Istituto Cardiocentro Ticino (CH)
St. Jude Medical (United States) (US)
Leiden University (NL)
St. Antonius Ziekenhuis (NL)
University of Bologna (IT)
Odense University Hospital (DK)
Boehringer Ingelheim (Germany) (DE)
Johns Hopkins University (US)
University of Oxford (GB)
Maastricht University Medical Centre (NL)
Daiichi Sankyo (Germany) (DE)
University of Duisburg-Essen (DE)
Lankenau Institute for Medical Research (US)
Ludwig-Maximilians-Universität München (DE)
University of Calgary (CA)
Ospedale Garibaldi (IT)
Bristol-Myers Squibb (Germany) (DE)
University Hospital Zurich (CH)
Sorbonne Université (FR)
Universitair Ziekenhuis Leuven (BE)
University of Lausanne (CH)
Institute of Clinical and Experimental Medicine (CZ)
Asklepios Klinik St. Georg (DE)
TUM Klinikum (DE)
Medtronic (Switzerland) (CH)
Hospital Clínic de Barcelona (ES)
Pfizer (Germany) (DE)
Aarhus University Hospital (DK)
Atrial Fibrillation NETwork (DE)
Hacettepe University (TR)
Medical University of Graz (AT)
University of Belgrade (RS)
Columbia University Irving Medical Center (US)
Bayer (Germany) (DE)
Boston Scientific (United States) (US)
Starnberg Hospital (DE)
University College Hospital (GB)
Uppsala University (SE)
ORCID: Kirchhof, P.
Auricchio, A.
Bailleul, C.
Bax, J.
Boersma, L.
Boriani, G.
Brandes, A.
Brueckmann, M.
Calkins, H.
Casadei, B.
Clemens, A.
Crijns, H.
Dobrev, D.
Gerth, A.
Gillis, A.
Gulizia, M.
Hack, G.
Haegeli, L.
Hatem, S.
Kautzner, J.
Lane, D.
Lewalter, T.
Meyer, R.
Mont, L.
Nielsen, J. C.
Pieske, B.
Pisters, R.
Potpara, T.
Ravens, U.
Reiffel, J.
Schotten, U.
Steinbeck, G.
Tavazzi, L.
Themistoclakis, S.
Thomitzek, K.
Werring, D.
Lip, G. Y. H.
Camm, A. J.
Venue: Europace
Publisher: Oxford University Press (OUP)
Published: 2013-08-27
Volume: 15
Issue: 11
Pages: 1540-1556
ISSN: 1099-5129 (ISSN-L)
1532-2092
DOI: 10.1093/europace/eut232
OpenAlex: W2105963090
Cited by: 141
References: 227
Citations by year: 2026: 1 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 4 · 2020: 7 · 2019: 11 · 2018: 8 · 2017: 18 · 2016: 20 · 2015: 26 · 2014: 29 · 2013: 2
FWCI: 17.43
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: EP Europace (publishedVersion)
PubMed (publishedVersion)
Research Publications (Maastricht University) (publishedVersion, other-oa)
University of Birmingham Research Portal (University of Birmingham) (publishedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Leiden Repository (Leiden University) (submittedVersion)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
Pure Amsterdam UMC (submittedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
INFM-OAR (INFN Catania) (submittedVersion, other-oa)
Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders: Wellcome Trust (090532)
Kompetenznetz Vorhofflimmern
British Heart Foundation (RG/11/15/29375)
European Commission
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords: atrial fibrillation, personalized medicine, risk stratification, direct oral anticoagulants, antiarrhythmic drugs, catheter ablation, rhythm control, atrial morphology, neuroimaging, genetic susceptibility, inflammation, stroke risk, heart failure
MeSH terms: Atrial Fibrillation, Brain, Echocardiography, Electrocardiography, Humans, Magnetic Resonance Imaging, Risk Factors, Biomarkers, Treatment Outcome, Disease Management, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks